Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 18, 2018 - Issue 1
Submit an article Journal homepage
608
Views
4
CrossRef citations to date
0
Altmetric
Review

Development of pneumococcal vaccines over the last 10 years

Nicola PrincipiPediatric Highly Intensive Care Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, ItalyCorrespondence[email protected]
View further author information
&
Susanna EspositoPaediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, ItalyView further author information
Pages 7-17 | Received 17 Jul 2017, Accepted 21 Sep 2017, Published online: 12 Oct 2017

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Ulrike K. Buchwald, Charles P. Andrews, John Ervin, James T. Peterson, Gretchen M. Tamms, David Krupa, Patrick Ajiboye, Lucy Roalfe, Andrea L. Krick, Tina M. Sterling, Meihua Wang, Jason C. Martin, Jon E. Stek, Melvin A. Kohn, Temitope Folaranmi, Chitrananda Abeygunawardana, Jonathan Hartzel & Luwy K. Musey. (2021) Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older. Human Vaccines & Immunotherapeutics 17:8, pages 2678-2690.
Read now
Susanna Esposito, Sonia Bianchini, Alberto Argentiero, Cosimo Neglia & Nicola Principi. (2020) How does one choose the appropriate pharmacotherapy for children with lower respiratory tract infections?. Expert Opinion on Pharmacotherapy 21:14, pages 1739-1747.
Read now
Nicola Principi & Susanna Esposito. (2019) Experimental and investigational drugs for the treatment of acute otitis media. Expert Opinion on Investigational Drugs 28:8, pages 687-694.
Read now
Ger T Rijkers, Laura IE Yousif, Simone MC Spoorenberg & Frans J van Overveld. (2018) Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly. Risk Management and Healthcare Policy 11, pages 55-65.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.